LS Investment Advisors’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-7,222
Closed -$57K 1335
2020
Q2
$57K Buy
7,222
+529
+8% +$4.38K ﹤0.01% 1140
2020
Q1
$54K Hold
6,693
﹤0.01% 1086
2019
Q4
$84K Hold
6,693
﹤0.01% 1169
2019
Q3
$60K Hold
6,693
﹤0.01% 1251
2019
Q2
$57K Hold
6,693
﹤0.01% 1265
2019
Q1
$51K Hold
6,693
﹤0.01% 1295
2018
Q4
$55K Hold
6,693
﹤0.01% 1243
2018
Q3
$66K Sell
6,693
-248
-4% -$2.57K ﹤0.01% 1244
2018
Q2
$68K Hold
6,941
﹤0.01% 1228
2018
Q1
$65K Buy
6,941
+300
+5% +$2.86K ﹤0.01% 1222
2017
Q4
$63K Sell
6,641
-1,401
-17% -$13.4K ﹤0.01% 1254
2017
Q3
$83K Hold
8,042
﹤0.01% 1200
2017
Q2
$67K Hold
8,042
﹤0.01% 1267
2017
Q1
$58K Sell
8,042
-592
-7% -$4.29K ﹤0.01% 1289
2016
Q4
$62K Buy
8,634
+473
+6% +$3.29K ﹤0.01% 1193
2016
Q3
$59K Hold
8,161
﹤0.01% 1167
2016
Q2
$48K Buy
8,161
+529
+7% +$3.5K ﹤0.01% 1229
2016
Q1
$49K Buy
7,632
+809
+12% +$4.34K ﹤0.01% 1183
2015
Q4
$44K Hold
6,823
﹤0.01% 1205
2015
Q3
$40K Hold
6,823
﹤0.01% 1238
2015
Q2
$60K Buy
+6,823
New +$57.3K ﹤0.01% 1092

Other funds holding SEM

LS Investment Advisors's SEM Position: Q3 2020 in Review

LS Investment Advisors sold out of Select Medical (SEM) in Q3 2020, closing a stake of 7,222 shares — an estimated $57K sold.

LS Investment Advisors first reported a position in SEM in Q2 2015 and held it in 21 quarters. The position peaked at $84K in Q4 2019. 197 funds tracked by Wall St. Rank hold SEM as of Q3 2020.

  • LS Investment Advisors reported no remaining Select Medical position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 7,222 Select Medical shares in Q3 2020, an estimated $57K.
  • LS Investment Advisors first reported a position in Select Medical in Q2 2015 and held it in 21 quarters.
  • LS Investment Advisors's Select Medical position peaked at $84K in Q4 2019.
  • 197 funds tracked by Wall St. Rank held Select Medical as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.